Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: A case-control study

Michael A. Thompson, Robert A. Kyle, L. Joseph Melton, Matthew F. Plevak, S. Vincent Rajkumar

Research output: Contribution to journalArticle

7 Scopus citations


Interleukin-6 (IL-6) and C-reactive protein (CRP, a surrogate marker for IL-6) are important in monoclonal gammopathy of undetermined significance (MGUS) and myeloma. Smoking and obesity may elevate CRP levels, while statins decrease CRP levels. A case-control study in 200 MGUS patients found that statin use, smoking history and obesity do not affect MGUS progression.

Original languageEnglish (US)
Pages (from-to)626-628
Number of pages3
Issue number5
StatePublished - May 1 2004



  • Hydroxymethylglutaryl-CoA reductose inhibitors
  • MGUS
  • Myeloma
  • Statin

ASJC Scopus subject areas

  • Hematology

Cite this